India  

‘Covaxin efficacy 78%, works against variants’

IndiaTimes Thursday, 22 April 2021
Indigenous Covid-19 vaccine Covaxin has shown an overall interim clinical efficacy of 78% in fighting Covid-19. It has also shown 100% efficacy against severe Covid-19 disease, its developers Bharat Biotech and Indian Council of Medical Research (ICMR) said on Wednesday.
0
shares
ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Disease caused by severe acute respiratory syndrome coronavirus 2

Power of faith of all Indians with you, PM Modi tells doctors

Prime Minister Narendra Modi on Monday interacted with doctors from across the country and thanked the medical fraternity for the exemplary fight against Covid...
IndiaTimes
Spanish football recovery: Up to 5,000 fans heading to La Liga games [Video]

Spanish football recovery: Up to 5,000 fans heading to La Liga games

Crowds are welcome to football stadiums after more than a year of games played closed behind doors due to COVID-19. Fans are back at the venues in Spain, but with restrictions on capacity and social distancing.

Credit: Euronews English    Duration: 02:34Published

Yogi issues special directives for COVID-19 management as UP sees decline in cases

The Department of Health and Medical Education has been asked to ensure that every patient with black fungus receives appropriate treatment.
DNA

BBV152 BBV152 Vaccine against COVID-19

Jharkhand Police: ₹ 35 lakh as fine from masses violating Covid norms  | Oneindia News [Video]

Jharkhand Police: ₹ 35 lakh as fine from masses violating Covid norms | Oneindia News

Thousands of people including Covid patients evacuated because of Cyclone Tauktae from Gujarat and Maharashtra; Bharat Biotech said that the company manufactured Covaxin is effective against the aggressively virulent strains of Covid detected in India and in the UK; Delhi police said that an Aam Admi Party party member is the brain behind the posters that appeared around parts of Delhi a few days ago; Delhi Chief Minister Arvind Kejriwal today said the Delhi government will take all necessary steps and precautions to check cases of black fungus or mucormycosis in the city; Jharkhand Police has collected over ₹ 35 lakh as fine from people for not wearing masks in public places. #CycloneTauktae #Covaxin #AAP #BlackFungus #JharkhandPolice

Credit: Oneindia    Duration: 03:39Published

Covaxin effectively neutralises all key emerging variants, says study published in Oxford journal

Indigenous Covid-19 vaccine Covaxin has been able to neutralise all key emerging variants, including the double mutant B.1.617 and B.1.1.7, which was first..
IndiaTimes

Chidambaram slams Centre for delay in decision taking regarding inviting other Covaxin manufacturers

In a series of tweets, Chidambaram said the suggestion for compulsory licences be issued to other manufacturers had been offered by the Congress four weeks..
IndiaTimes

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer


Indian Council of Medical Research Indian Council of Medical Research Government Organization

Uttar Pradesh chief minister Yogi Adityanath visits Aligarh Muslim University after several faculty deaths

Uttar Pradesh chief minister Yogi Adityanath on Thursday visited AMU’s Jawaharlal Nehru Medical College to review the prevailing Covid-19 situation in the..
IndiaTimes

Covid-19: Most of country should remain locked down for 6-8 weeks, ICMR chief says

The head of the main Indian health agency responding to the coronavirus has said districts reporting a high number of infections should remain locked down for..
IndiaTimes

You Might Like


Related news from verified sources

Only 2-4 infections per 10k found in those vaccinated with two doses: ICMR

In a strong validation of the utility of vaccines in combating Covid 19, the Indian Council of Medical Research (ICMR) on Wednesday said only 2-4 per 10,000...
IndiaTimes

Covid-19 vaccines are disease-modifying, reduce chances of severe infection, mortality: ICMR chief

Covid-19 vaccines reduce the chances of developing severe infection and mortality, ICMR chief Balram Bhargava said on Tuesday.
IndiaTimes Also reported by •BGR India

‘Covaxin efficacy 78%, works against variants’

Indigenous Covid-19 vaccine Covaxin has shown an overall interim clinical efficacy of 78% in fighting Covid-19. It has also shown 100% efficacy against severe...
IndiaTimes